Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-25

Clinical Trial Update: Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is recruiting to evaluate the combined use of thiamine and biotin in Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIotiN (biotin)
  • Thiamine (thiamine)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Huntington Disease | Phase 2 | Status: RECRUITING